CTRMAXXING ∕∕ SIGNAL DROP · MAY ’26NETWORK ONLINE · 1,248 OPERATORS
ctrmaxxingv0.4 · invite-only
MEDICAL · NICHE PROFILE

Longevity science.

Evidence-based coverage of aging research, lifespan studies, and what science actually supports. Premium RPM, strong search demand, needs disciplined, hype-free sourcing.

AVG RPM
$8 to $16
GROWTH
Hot
UPLOADS
1 per week

What works in this niche

  • Separating what is proven from what is still hopeful
  • Explaining the actual mechanism behind a claim
  • Naming the quality and size of the underlying studies
  • Resisting the supplement-hype framing the niche invites
  • A grounded takeaway about what the evidence supports today

Format: 9 to 15 minute explainers. Study-summary graphics, mechanism diagrams, a measured evidence-first narration that separates promising research from marketing.

Hook patterns that earn clicks

  • Question hook: 'this is everywhere online, but does the research hold up'
  • Data shock: 'the headline came from a study in mice, not people'
  • Myth-statement cold open: a popular claim, then the real evidence

Sub-niches to mine

Narrower angles inside this niche with room to own a lane.

  • Aging-mechanism research explained
  • Lifespan-study claims tested
  • Supplement and protocol evidence
  • Human versus animal study results
  • Separating hype from real findings

Top performers we track

Anonymized to protect operators. Revenue figures are estimates from public engagement, not declared earnings.

Channel A
~$45k
13 min evidence explainers
Channel B
~$24k
aging-research breakdowns
Channel C
~$12k
10 min claim-testing videos
Channel D
~$6k
short longevity-science clips

Common pitfalls

  • Promoting unproven supplements or protocols as fact
  • Overstating animal-study results as human findings
  • Offering medical advice rather than summarizing evidence
  • Hype framing that draws limited advertiser inventory

FAQ

Why does longevity science carry such a high RPM?

It draws premium health, supplement, and wellness advertisers and skews toward an older, higher-value audience. As long as the framing stays evidence-first and hype-free, it sits at the top of this batch on RPM.

How do I avoid the supplement-grifter trap?

Never promote a protocol as proven, always cite study quality and whether findings are human or animal, and add a not-medical-advice note. The operator-tracked channels that last here are skeptical, not promotional.

Is the science solid enough to cover responsibly?

Much of it is early and mixed, which is exactly the angle. Honestly weighing promising-but-unproven research, and saying so plainly, differentiates a serious channel from the hype crowd.

· pipeline · founding waitlist ·

Want the full pipeline tuned for longevity science?

Script, five A/B titles, SEO description, and thumbnail. Tuned per channel archetype. From operators with 1B+ views.